WHO international standard for SARS-CoV-2 antibodies to determine markers of protection

Lancet Microbe. 2022 Feb;3(2):e81-e82. doi: 10.1016/S2666-5247(21)00307-4. Epub 2021 Dec 3.

Authors

Feng Zhu¹, Thomas Althaus^{2

3}, Chee Wah Tan¹, Alizée Costantini², Wan Ni Chia¹, Nguyen Van Vinh Chau⁴, Le Van Tan⁵, Giada Mattiuzzo⁶, Nicola J Rose⁶, Eric Voiglio³, Lin-Fa Wang^{1

7}

Affiliations

¹ Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169657.
² Centre Scientifique de Monaco, Monaco.
³ Direction de l'Action Sanitaire in Monaco, Monaco.
⁴ Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
⁵ Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
⁶ National Institute for Biological Standards and Control, MHRA, South Mimms, UK.
⁷ SingHealth Duke-NUS Global Health Institute, Singapore.

No abstract available

MeSH terms

Antibodies, Viral
COVID-19 Serological Testing
COVID-19*
Humans
SARS-CoV-2*
World Health Organization

Substances

Antibodies, Viral

Grants and funding

204904/Z/16/Z/WT_/Wellcome Trust/United Kingdom